Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma

OBJECTIVES: To evaluate the toxicity and efficacy of capecitabine and weekly docetaxel in a phase II clinical trial. METHODS: Eligibility included metastatic renal cancer with a maximum of 2 prior regimens, performance status of 0-2, and adequate renal, hepatic, and bone marrow function. Docetaxel w...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Marur, Shanthi, Eliason, James, Heilbrun, Lance K., Dickow, Brenda, Smith, Daryn W., Baranowski, Karen, Alhasan, Samir, Vaishampayan, Ulka
Format: Artigo
Jezik:Inglês
Izdano: 2008
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3859296/
https://ncbi.nlm.nih.gov/pubmed/18692873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urology.2008.05.032
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki